News and features

Press Release - Premarket approval for the Neuroform Atlas® Stent System

Stryker receives FDA premarket approval for the Neuroform Atlas® Stent System to treat brain aneurysms

More

Press release – Stryker launches next generation flow diverter for treatment of brain aneurysms

Stryker announces the availability of the Surpass Evolve Flow Diverter following CE mark approval in March.

More

Innovation, design, and a look to the future of stroke technology

An interview with John Daniel, Vice President, Neurovascular R&D

More

Product Bulletin: Surpass Streamline™ Flow Diverter

Stryker receives US FDA Pre-market approval for the Surpass Streamline™ Flow Diverter to treat large and giant unruptured aneurysms

More

Trevo Retriever First and Only Device for Treatment up to 24 hrs

Stryker’s Trevo® Retriever becomes first and only device indicated for treatment up to 24 hours, aligning with new AHA/ASA guidelines

More

Stryker’s WEAVE Trial demonstrates positive results of endovascular treatment for patients with ICAD

Results from the Wingspan® StEnt System Post MArket SurVEillance Study (WEAVE™ Trial) were presented yesterday at the International Stroke Conference, providing compelling evidence that...

More

Stryker’s DAWN Trial results contribute to updated acute ischemic stroke guidelines from the AHA/ASA

Yesterday the American Heart Association and American Stroke Association updated the ischemic stroke guidelines. The new recommendation expanded the treatment window from six to 16 hours based...

More

Stryker announces publication of the DAWN™ Trial results in the New England Journal of Medicine

The New England Journal of Medicine published the results of the DAWN Trial, the first to provide compelling evidence in treating late window and wake-up stroke patients with mechanical thrombectomy.

More

Stryker receives US FDA HDE approval for the Neuroform Atlas™ Stent System

Stryker Corporation announced today that the U.S. Food and Drug Administration has approved the Neuroform Atlas™

More

Celebrating Stroke Survivors – World Stroke Day 2017

Learn more about stroke survivors and stroke treatment.

More

TRACK registry

Exclusive interview with Dr. Zaidat, PI of the TRACK Registry.

More

Product Bulletin: DAWN™ Trial Results

DAWN™ Trial results demonstrate a 73% reduction in disability in stroke patients treated up to 24 hours.

More

Product Bulletin: DAWN™ Trial

Stryker announces an early stop to enrollment in the DAWN™ Trial due to the high probability of trial success.

More

Ann McCafferty discusses the nomination of Trevo® XP ProVue Retriever

Ann McCafferty discusses the nomination of Trevo® XP ProVue Retriever for the Prix Galien Discovery of the Decade: Best medical technology product.

More

NEW Indication for Trevo Retrievers

The latest Information on the new Indication for Trevo Retrievers

More

Study Published In The New England Journal Of Medicine Finds….

Prix Galien-winning Stryker Trevo among those stent retrievers used in the trial

More

Stryker Receives Prestigious 2014 Prix Galien Award For Best Medical Technology

Stryker Corporation's Trevo® ProVue Retriever has received the Prix Galien USA 2014 Award for Best Medical Technology.

More
Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×